Cosmetic cross-reference Noindex: medium evidence

Lime

CAS 1305-78-8

Lime (CAS 1305-78-8) is a Phase 3 pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

0

SOURCE DrugCentral

Adverse signals

0

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Lime

CAS Number

1305-78-8

UNII

C7X2M0VVNH

InChIKey

BRPQOXSCLDDYGP-UHFFFAOYSA-N

ChEMBL ID

CHEMBL5314372

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3

Late-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL5314372 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Lime used for in pharmaceutical contexts?

Lime (CAS 1305-78-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Lime?

No adverse-event association or SIDER side-effect rows are rendered for Lime in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Lime also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Calcium Oxide with EU status "prohibited".

What clinical phase is Lime in?

Lime is rendered with ChEMBL max phase 3.